Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Reliance Global Group, Inc. (EZRA)

Reliance Global Group completes $8 million sale of Altruis Benefit Consulting

Neutral Impact 3 of 5 m&a Written later

Reliance Global Group said it completed the sale of substantially all assets of its Altruis Benefit Consulting subsidiary, a Michigan-based health insurance agency, for an $8 million cash purchase price plus an earnout of up to $1 million over three years. The company said the proceeds strengthen its balance sheet and will be redeployed into its AI platform, RELI Exchange, and other growth initiatives, and the filing does not quantify the effect of the sale on revenue or earnings.

Key points

  • Cash purchase price of $8 million; about $7.5 million received, including full payment of the buyer's $3.1 million seller note on September 30, 2026
  • $461,729 held by the buyer as indemnity and working capital holdbacks
  • Earnout of up to $1 million over three years, based on annual revenue growth of the acquired business
  • Sale closed September 23, 2026, following the September 11, 2026 sale of Southwestern Montana Insurance Center

The filing

CompanyReliance Global Group, Inc. (EZRA)
Form8-K, current report
Filed with the SECOct 5, 2026, 5:27 PM ET
Accession number0001493152-26-045782

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.